Colin Kovacs

Maple Leaf Medical Clinic — Canada

Immunology and Microbiology · Life Sciences

51h-index8.7kcitations160works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(117), HIV/AIDS Research and Interventions(53), Immune Cell Function and Interaction(49), HIV/AIDS drug development and treatment(43), T-cell and B-cell Immunology(21)

Publications160 total

Nef-mediated ARP2/3 inhibition drives CD4+ T cell dysfunction and dysregulated immunity in HIV progressors 2658
The Journal of Immunology·2025Open Access
Spatial characterization of immunosenescence within HIV infected lymph nodes 2718
The Journal of Immunology·2025Open Access
The latency reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific CD8+ T-cells
UNC Libraries·2025· 1 citedOpen Access
Human RIG-I deficiency confers susceptibility to Kaposi Sarcoma via loss of latency control
2025
Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies
Journal of Clinical Investigation·2025· 4 citedOpen Access
Sa1973: AN AI-DESIGNED BACTERIOPHAGE COCKTAIL FOR MICROBIOME EDITING IN THE TREATMENT OF CROHN’S DISEASE
Gastroenterology·2025
PP1.2 – 00165 Inhibition of ARP2/3 by HIV Nef Leads to Impaired CD4+ T Cell Function & Dysregulation of Immunity within Progressors but not all HIV Controllers
Journal of Virus Eradication·2024Open Access
PP1.11 – 00021 Impact of HIV-1 Tat and TAR Sequence Diversity on Clinical and Reservoir Characteristics
Journal of Virus Eradication·2024Open Access
Sex differences in COVID-19 vaccine confidence in people living with HIV in Canada
Vaccine X·2024· 3 citedOpen Access
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study
Vaccines·2024· 3 citedOpen Access
Effective and targeted latency reversal in CD4 <sup>+</sup> T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection
Emerging Microbes & Infections·2024· 6 citedOpen Access
Sex Differences in Covid-19 Vaccine Confidence in People Living with HIV in Canada
SSRN Electronic Journal·2024Open Access
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
iScience·2023· 24 citedOpen Access
The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells
JCI Insight·2023· 11 citedOpen Access
Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada
AIDS·2023· 7 citedOpen Access
A Subset of HIV-1 Controllers Lack Cortical Actin Disruption Indicative of ARP2/3 Inhibition
2023Open Access
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy
Journal of Clinical Investigation·2023· 115 citedOpen Access
Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV
2023· 2 citedOpen Access
Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey
AIDS and Behavior·2023· 13 citedOpen Access
Immunogenicity of COVID-19 Vaccines and Their Effect on the HIV Reservoir in Older People with HIV
SSRN Electronic Journal·2023· 1 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Mario Ostrowski(24), Erika Benko(19), Rupert Kaul(17), R. Brad Jones(13), Mona Loutfy(11), Prameet M. Sheth(10), Feng Yun Yue(9), Anthony S. Fauci(9), Tae‐Wook Chun(8), J. Shawn Justement(7), Claire W. Hallahan(7), Szu-Han Huang(6), Bruce D. Walker(6), Susan Moir(6), Sanja Huibner(6), Roberta Halpenny(5), Lucy Y. Shin(5), Duncan Chege(5), Gabor Kandel(5), Kiera Clayton(5)